Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Garcia-Gonzalez, X; Lopez-Tarruella, S; Garcia, MI; Gonzalez-Haba, E; Blanco, C; Salvador-Martin, S; Jerez, Y; Thomas, F; Jarama, M; Saez, MS; Martin, M; Lopez-Fernandez, LA.

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

Cancer Management and Research. 2018; 10: 4517-4522 Nº de citas: 4 [doi:10.2147/CMAR.S174470]

Castellano, D; Maroto, JP; Espinosa, E; Grande, E; Bolos, MV; Llinares, J; Esteban, E; del Alba, AG; Climent, MA; Arranz, JA; Mendez, MJ; Parra, EF; Anton-Aparicio, L; Bayona, C; Gallegos, I; Gallardo, E; Samaniego, L; Donas, JG.

Experience with Sunitinib in metastatic renal cell carcinoma (mRCC) patients: pooled analysis from 3 Spanish observational prospective studies

EXPERT OPINION ON DRUG SAFETY. 2018; 17(6): 573-579 Nº de citas: 2 [doi:10.1080/14740338.2017.1330410]

Martin, AM; Hidalgo, M; Alvarez, R; Arrazubi, V; Martinez-Galan, J; Salgado, M; Macarulla, T; Carrato, A.

From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer

Journal of Cancer. 2018; 9(11): 1978-1988 Nº de citas: 26 [doi:10.7150/jca.23716]

Carles, J; Mendez, MJ; Pinto, A; Saez, MI; Arranz, JA; Maroto, P; Lopez-Criado, P; Mellado, B; Donas, JG; Hernando, S; Leon, L; del Alba, AG; Lainez, N; Esteban, E; Reynes, G; Perez-Gracia, JL; Germa, JR; Lopez-Brea, M; Perez-Valderrama, B; Moretones, C; Castellano, D.

Radium-223 international early access program: results from the Spanish subset

Future Oncology. 2018; 14(1): 41-50 Nº de citas: 4 [doi:10.2217/fon-2017-0297]

Ruiz-Pinto, S; Pita, G; Martin, M; Alonso-Gordoa, T; Barnes, DR; Alonso, MR; Herraez, B; Garcia-Miguel, P; Alonso, J; Perez-Martinez, A; Carton, AJ; Gutierrez-Larraya, F; Garcia-Saenz, JA; Benitez, J; Easton, DF; Patino-Garcia, A; Gonzalez-Neira, A.

Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients

BREAST CANCER RESEARCH AND TREATMENT. 2018; 167(1): 249-256 Nº de citas: 21 [doi:10.1007/s10549-017-4497-9]

Docampo, LCI; Arrula, VA; Rotllan, NB; Maseda, AC; Cirauqui, BC; Escobar, Y; Sorrosal, JJL; Borgonon, MP; Rueda, A; Hernandez, JJC.

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(1): 75-83 Nº de citas: 21 [doi:10.1007/s12094-017-1776-1]

Berrocal, A; Arance, A; Castellon, VE; de la Cruz, L; Espinosa, E; Cao, MG; Larriba, JLG; Marquez-Rodas, I; Soria, A; Algarra, SM.

SEOM clinical guideline for the management of malignant melanoma (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(1): 69-74 Nº de citas: 12 [doi:10.1007/s12094-017-1768-1]

Cassinello, J; Arranz, JA; Piulats, JM; Sanchez, A; Perez-Valderrama, B; Mellado, B; Climent, MA; Olmos, D; Carles, J; Lazaro, M.

SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2018; 20(1): 57-68 Nº de citas: 15 [doi:10.1007/s12094-017-1783-2]

Hurvitz, SA; Martin, M; Symmans, WF; Jung, KH; Huang, CS; Thompson, AM; Harbeck, N; Valero, V; Stroyakovskiy, D; Wildiers, H; Campone, M; Boileau, JF; Beckmann, MW; Afenjar, K; Fresco, R; Helms, HJ; Xu, J; Lin, YG; Sparano, J; Slamon, D.

Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial

LANCET ONCOLOGY. 2018; 19(1): 115-126 Nº de citas: 421 [doi:10.1016/S1470-2045(17)30716-7]

Alberro, JA; Ballester, B; Deulofeu, P; Fabregas, R; Fraile, M; Gubern, JM; Janer, J; Moral, A; de Pablo, JL; Penalva, G; Puig, P; Ramos, M; Rojo, R; Santesteban, P; Serra, C; Sola, M; Solarnau, L; Solsona, J; Veloso, E; Vidal, S; Abe, O; Abe, R; Enomoto, K; Kikuchi, K; Koyama, H; Masuda, H; Nomura, Y; Ohashi, Y; Sakai, K; Sugimachi, K; Toi, M; Tominaga, T; Uchino, J; Yoshida, M; Coles, CE; Haybittle, JL; Mobus, V; Leonard, CF; Calais, G; Garaud, P; Collett, V; Davies, C; Delmestri, A; Sayer, J; Harvey, VJ; Holdaway, IM; Kay, RG; Mason, BH; Forbe, JF; Franci, PA; Wilcken, N; Balic, M; Bartsch, R; Fesl, C; Fitzal, F; Fohler, H; Gnant, M; Greil, R; Jakesz, R; Marth, C; Mlineritsch, B; Pfeiler, G; Singer, CF; Steger, GG; Stoger, H; Canney, P; Yosef, HMA; Focan, C; Peek, U; Oates, GD; Powell, J; Durand, M; Mauriac, L; Di Leo, A; Dolci, S; Larsimont, D; Nogaret, JM; Philippson, C; Piccart, MJ; Masood, MB; Parker, D; Price, JJ; Lindsay, MA; Mackey, J; Martin, M; Hupperets, PSGJ; Bates, T; Blamey, RW; Chetty, U; Ellis, IO; Mallon, E; Morgan, DAL; Patnick, J; Pinder, S; Lohrisch, C; Nichol, A; Bartlett, JMS; Bramwell, VH; Chen, BE; Chia, SKL; Gelmon, K; Goss, PE; Levine, MN; Parulekar, W; Pater, JL; Pritchard, KI; Shepherd, LE; Tu, D; Whelan, T; Berry, D; Broadwater, G; Cirrincione, C; Muss, H; Norton, L; Weiss, RB; Abu-Zahara, HT; Karpov, A; Portnoj, SL; Bowden, S; Brookes, C; Dunn, J; Fernando, I; Lee, M; Poole, C; Rea, D; Spooner, D; Barrett-Lee, PJ; Manse, RE; Monypenny, IJ; Gordon, NH; Davis, HL; Cuzick, J; Sestak, I; Lehingue, Y; Romestaing, P; Dubois, JB; Delozier, T; Griffon, B; Lesec'H, JM; Mustacchi, G; Petruzelka, L; Pribylova, O; Owen, JR; Meier, P; Shan, Y; Shao, YF; Wang, X; Zhao, DB; Howell, A; Swindell, R; Albano, J; de Oliveira, CF; Gervasio, H; Gordilho, J; Ejlertsen, B; Jensen, MB; Mouridsen, H; Gelman, RS; Harris, JR; Hayes, D; Henderson, C; Shapiro, CL; Christiansen, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Mouridsen, HT; Fehm, T; Trampisch, HJ; Dalesio, O; de Vries, EGE; Rodenhuis, S; van Tinteren, H; Comis, RL; Davidson, NE; Gray, R; Robert, N; Sledge, G; Solin, LJ; Sparano, JA; Tormey, DC; Wood, W; Cameron, D; Chetty, U; Dixon, JM; Forrest, P; Jack, W; Kunkler, I; Rossbach, J; Klijn, JGM; Treurniet-Donker, AD; van Putten, WLJ; Rotmensz, N; Veronesi, U; Viale, G; Bartelink, H; Bijker, N; Bogaerts, J; Cardoso, F; Cufer, T; Julien, JP; Poortmans, PM; Rutgers, E; van de Velde, CJH; Cunningham, MP; Huovinen, R; Joensuu, H; Costa, A; Bonadonna, G; Gianni, L; Valagussa, P; Goldstein, LJ; Bonneterre, J; Fargeot, P; Fumoleau, P; Kerbrat, P; Lupors, E; Namer, M; Carrasco, E; Martin, M; Segui, MA; Eierman, W; Hilfrich, J; Jonat, W; Kaufmann, M; Kreienberg, R; Schumacher, M; Bastert, G; Rauschecker, H; Sauer, R; Sauerbrei, W; Schauer, A; Schumacher, M; Blohmer, JU; Costa, SD; Eidtmann, H; Gerber, B; Jackisch, C; Loib, S; von Minckwitz, G; de Schryver, A; Vakaet, L; Belfiglio, M; Nicolucci, A; Pellegrini, F; Pirozzoli, MC; Sacco, M; Valentini, M; McArdle, CS; Smith, DC; Stallard, S; Dent, DM; Gudgeon, CA; Hacking, A; Murray, E; Panieri, E; Werner, ID; De Salvo, GL; Del Bianco, P; Zavagno, G; Leone, B; Vallejo, CT; Zwenger, A; Galligioni, E; Lopez, M; Erazo, A; Medina, JY; Horiguchi, J; Takei, H; Fentiman, IS; Hayward, JL; Rubens, RD; Skilton, D; Scheurlen, H; Kaufmann, M; Sohn, HC; Untch, M; Dafni, U; Markopoulos, C; Bamia, C; Fountzilas, G; Koliou, GA; Manousou, K; Mavroudis, D; Klefstrom, P; Blomqvist, C; Saarto, T; Gallen, M; Canavese, G; Tinterri, C; Margreiter, R; de Lafontan, B; Mihura, J; Roche, H; Asselain, B; Salmon, RJ; Vilcoq, JR; Brain, E; de La Lande, B; Mouret-Fourme, E; Andre, F; Arriagada, R; Delaloge, S; Hill, C; Koscienly, S; Michiels, S; Rubino, C; A'Hern, R; Bliss, J; Ellis, P; Kilburn, L; Yarnold, JR; Martin, M; Benraadt, J; Kooi, M; van de Velde, AO; van Dongen, JA; Vermorken, JB; Castiglione, M; Coates, A; Colleoni, M; Collins, J; Forbes, J; Gelbe, RD; Goldhirsch, A; Lindtner, J; Price, KN; Regan, MM; Rudenstam, CM; Senn, HJ; Thuerlimann, B; Bliss, JM; Chilvers, CED; Coombes, RC; Hall, E; Marty, M; Buyse, M; Possinger, K; Schmid, P; Untch, M; Wallwiener, D; Foster, L; George, WD; Stewart, HJ; Stroner, P; Borovik, R; Hayat, H; Inbar, MJ; Peretz, T; Robinson, E; Camerini, T; Formelli, F; Martelli, G; Di Mauro, MG; Valagussa, P; Perrone, F; Amadori, D; Martoni, A; Pannuti, F; Camisa, R; Musolino, A; Passalacqua, R; Iwata, H; Shien, T; Abe, O; Ikeda, T; Inokuchi, K; Kikuchi, K; Sawa, K; Sonoo, H; Sadoon, M; Tulusan, AH; Kohno, N; Miyashita, M; Takao, S; Ahn, JH; Jung, KH; Korzeniowski, S; Skolyszewski, J; Ogawa, M; Yamashita, J; Bastiaannet, E; Liefers, GJ; van de Velde, CJH; Christiaens, R; Neven, P; Paridaens, R; Van den Bogaert, W; Gazet, JC; Corcoran, N; Deshpande, N; di Martino, L; Douglas, P; Hacking, A; Host, H; Lindtner, A; Notter, G; Bryant, AJS; Ewing, GH; Firth, LA; Krushen-Kosloski, JL; Nissen-Meyer, R; Anderson, H; Killander, F; Malmstrom, P; Ryden, L; Arnesson, LG; Carstense, J; Dufmats, M; Fohlin, H; Nordenskjold, B; Soderberg, M; Sundqvist, M; Carpenter, TJ; Murray, N; Royle, GT; Simmonds, PD; Albain, K; Barlow, W; Crowley, J; Hayes, D; Gralow, J; Hortobagyi, G; Livingston, R; Martino, S; Osborne, CK; Ravdin, PM; Bergh, J; Bondesso, T; Celebiogl, F; Dahlberg, K; Fornander, T; Fredriksson, I; Frisell, J; Goransson, E; Iiristo, M; Johansson, U; Lenner, E; Lofgren, L; Nikolaidis, P; Perbeck, L; Rotstein, S; Sandelin, K; Skoog, L; Svane, G; af Trampe, E; Wadstrom, C; Janni, W; Castiglione, M; Goldhirsch, A; Maibach, R; Senn, HJ; Thurlimann, B; Bartlett, JMS; Bastiaannet, E; Hadji, P; Hozumi, J; Rea, D; van de Velde, CJH; Holli, K; Rouhento, K; Safra, T; Brenner, H; Hercbergs, A; Yoshimoto, M; Paterson, AHG; Pritchard, KI; Fyles, A; Meakin, JW; Panzarella, T; Pritchard, KI; Bahi, J; Delaloge, S; Lemonnier, J; Martin, AL; Reid, M; Spittle, M; Bishop, H; Bundred, NJ; Cuzick, J; Ellis, IO; Fentiman, IS; Forbes, JF; Forsyth, S; George, WS; Pinder, SE; Sestak, I; Deutsch, GP; Gray, R; Kwong, DLW; Pai, VR; Peto, R; Senanayake, F; Boccardo, F; Rubagotti, A; Baum, M; Forsyth, S; Hackshaw, A; Houghton, J; Ledermann, J; Monson, K; Tobias, JS; Carlomagno, C; De Laurentiis, M; De Placido, S; Schem, C; Williams, L; Bell, R; Cameron, D; Coleman, RE; Dodwell, D; Hinsley, S; Marshall, HC; Hayes, D; Pierce, LJ; Basso, SMM; Lumachi, F; Solomayer, E; Coleman, RE; Horsman, JM; Lester, J; Winter, MC; Buzdar, AU; Hsu, L; Love, RR; Ahlgren, J; Garmo, H; Holmberg, L; Lindman, H; Warnberg, F; Asmar, L; Jones, SE; Aft, R; Gluz, O; Harbeck, N; Liedtke, C; Nitz, U; Litton, A; Wallgren, A; Karlsson, P; Linderholm, BK; Chlebowski, RT; Caffier, H; Brufsky, AM; Coleman, RE; Llombart, HA; EBCTCG; EBCTCG; GROCTA Trialists.

Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

LANCET ONCOLOGY. 2018; 19(1): 27-39 Nº de citas: 851 [doi:10.1016/S1470-2045(17)30777-5]

Carmona-Bayonas, A; Jimenez-Fonseca, P; Custodio, A; Canovas, MS; Hernandez, R; Pericay, C; Echavarria, I; Lacalle, A; Visa, L; Palomo, AR; Mangas, M; Cano, JM; Buxo, E; Alvarez-Mancenido, F; Garcia, T; Lorenzo, JE; Ferrer-Cardona, M; Viudez, A; Azkarate, A; Ramchandani, A; Arias, D; Longo, F; Lopez, C; Bayona, RS; Limon, ML; Diaz-Serrano, A; Montes, AF; Sala, P; Cerda, P; Rivera, F; Gallego, J.

Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the AGAMEMON National Cancer Registry

Gastric Cancer. 2018; 21(1): 96-105 Nº de citas: 17 [doi:10.1007/s10120-017-0718-5]

Algarra, SM; Soriano, V; Fernandez-Morales, L; Berciano-Guerrero, MA; Mujika, K; Manzano, JL; Hernandez, TP; Soria, A; Rodriguez-Abreu, D; Arranz, EE; Martinez, JM; Marquez-Rodas, I; Rubio-Casadevall, J; Ortega, ME; Garcia, JMJ; Biurrun, MJL; Palacio, I; Artacho, MRD; Altozano, JP; Rubio, VEC; Garcia, A; Luna, P; Ballesteros, A; Fernandez, O; Martin, JAL; Berrocal, A; Arance, A.

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study

MEDICINE. 2017; 96(52): Nº de citas: 8 [doi:10.1097/MD.0000000000009523]

Climent, MA; Perez-Valderrama, B; Mellado, B; Parra, EMF; Calvo, OF; de Olza, MO; Romay, LM; Anido, U; Domenech, M; Polo, SH; Arija, JAA; Caballero, C; Fita, MJJ; Castellano, D.

Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial

EUROPEAN JOURNAL OF CANCER. 2017; 87: 30-37 Nº de citas: 19 [doi:10.1016/j.ejca.2017.09.028]

Martin, M; Holmes, FA; Ejlertsen, B; Delaloge, S; Moy, B; Iwata, H; von Minckwitz, G; Chia, SKL; Mansi, J; Barrios, CH; Gnant, M; Tomasevic, Z; Denduluri, N; Separovic, R; Gokmen, E; Bashford, A; Borrego, MR; Kim, SB; Jakobsen, EH; Ciceniene, A; Inoue, K; Overkamp, F; Heijns, JB; Armstrong, AC; Link, JS; Abraham, A; Bryce, JR; Wong, A; Moran, S; Yao, B; Xu, F; Auerbach, A; Buyse, M; Chan, A; ExteNET Study Grp.

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

LANCET ONCOLOGY. 2017; 18(12): 1688-1700 Nº de citas: 508 [doi:10.1016/S1470-2045(17)30717-9]

Martin, AJM; Adeva, J; Martinez-Galan, J; Reina, JJ; Hidalgo, M.

Pancreatic ductal adenocarcinoma: metastatic disease

CLINICAL & TRANSLATIONAL ONCOLOGY. 2017; 19(12): 1423-1429 Nº de citas: 9 [doi:10.1007/s12094-017-1690-6]

Redondo, A; Bague, S; Bernabeu, D; Ortiz-Cruz, E; Valverde, C; Alvarez, R; Martinez-Trufero, J; Lopez-Martin, JA; Correa, R; Cruz, J; Lopez-Pousa, A; Santos, A; del Muro, XG; Martin-Broto, J.

Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)

CANCER CHEMOTHERAPY AND PHARMACOLOGY. 2017; 80(6): 1113-1131 Nº de citas: 41 [doi:10.1007/s00280-017-3436-0]

van Krieken, JH; Kafatos, G; Bennett, J; Mineur, L; Tomasek, J; Rouleau, E; Fabian, P; De Maglio, G; Garcia-Alfonso, P; Aprile, G; Parkar, P; Downey, G; Demonty, G; Trojan, J.

Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review

BMC CANCER. 2017; 17: Nº de citas: 8 [doi:10.1186/s12885-017-3740-4]

Weber, J; Mandala, M; Del Vecchio, M; Gogas, HJ; Arance, AM; Cowey, CL; Dalle, S; Schenker, M; Chiarion-Sileni, V; Marquez-Rodas, I; Grob, JJ; Butler, MO; Middleton, MR; Maio, M; Atkinson, V; Queirolo, P; Gonzalez, R; Kudchadkar, RR; Smylie, M; Meyer, N; Mortier, L; Atkins, MB; Long, GV; Bhatia, S; Lebbe, C; Rutkowski, P; Yokota, K; Yamazaki, N; Kim, TM; de Pril, V; Sabater, J; Qureshi, A; Larkin, J; Ascierto, PA; CheckMate 238 Collaborators.

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

NEW ENGLAND JOURNAL OF MEDICINE. 2017; 377(19): 1824-1835 Nº de citas: 1833 [doi:10.1056/NEJMoa1709030]